Lang, Chim

Professor

  • 11524 Citations
  • 52 h-Index
1985 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Teaching

Full contribution to teaching in Dundee, especially cardiology and clinical pharmacology. External undergraduate examinerships (National University of Singapore, University of Malaya, International Medical University, Malaysia, National University of Malaysia). Supervisor of 25 MD/PhDs personally. External examiner for PhD/ MD (Universities of Birmingham, Cardiff, Edinburgh, Glasgow, Aberdeen, Hull)

Biography

Professor Lang is a consultant cardiologist and clinical pharmacologist and Professor of Cardiology at Ninewells Hospital and Medical School, Dundee, United Kingdom. He trained in both cardiology and clinical pharmacology in the United Kingdom and in the United States where he was a Merck International Fellow in Clinical Pharmacology at Vanderbilt University, Nashville and a Fulbright Scholar at Columbia University, New York. He is a Fellow of the Royal Colleges of Physicians of London and Edinburgh and the American College of Cardiology and European Society of Cardiology.

Research

Professor Lang is a translational cardiologist with a track record of research excellence in the area of cardio-metabolic diseases. He has published >250 papers in major journals, including NEJM, Lancet, European Heart Journal, JACC and Circulation. His research takes a multi-disciplinary approach to the understanding of the pathophysiology and pharmacogenetics of cardiovascular diseases and to the development of treatment strategies in patients with cardiovascular diseases. He leads an integrated cardiovascular research laboratory dedicated and equipped to the study of cardiac and vasomotor regulation. These techniques are applied towards translational research and in the development of biomarkers and novel treatment strategies in patients with cardiovascular diseases. Prof Lang is WP Co-Lead in the €12.3M IMI2-CARDIATEAM project on diabetic cardiomyopathy and was WP lead in the €11.9M FP-7 BIOSTAT system biology project on heart failure and is the Chief Investigator of the BHF funded MET-REMODEL and RECEDE trials and the EFSD funded REFORM trial. He is also the lead Applicant of the MRC funded MRC UK-Malaysia Partnership on the Precision medicine for diabetic Individuals: a joint Malaysia-UK Effort (PRIME) project. He is the UK National Coordinator of the multi-international COMMANDER-HF and SELECT trials. A wide range of funding bodies including the British Heart Foundation, MRC, Chief Scientist Office, EASD, Chest Heart and Stroke Scotland, Tenovus and the European commission Seventh Framework (FP-7) and Horizon 2020 Programmes funds his research. 

Research interests

Undertaking research on COVID-19 to address the current coronavirus pandemic.

Education/Academic qualification

Doctor of Medicine, University of Dundee

Award Date: 17 Jul 1993

Bachelor of Medicine and Bachelor of Surgery, University of Dundee

Award Date: 1 Jan 1985

Bachelor of Science, University of Dundee

Award Date: 1 Jan 1982

Keywords

  • RM Therapeutics. Pharmacology
  • Cardiology

Fingerprint Dive into the research topics where Chim Lang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failure

Sama, I. E., Woolley, R. J., Nauta, J. F., Romaine, S. P. R., Tromp, J., Ter Maaten, J. M., van der Meer, P., Lam, C. S. P., Samani, N. J., Ng, L. L., Metra, M., Dickstein, K., Anker, S. D., Zannad, F., Lang, C. C., Cleland, J. G. F., van Veldhuisen, D. J., Hillege, H. L. & Voors, A. A., May 2020, In : European Journal of Heart Failure. 22, 5, p. 821-833 13 p.

Research output: Contribution to journalArticle

Open Access
File
  • 1 Citation (Scopus)
    13 Downloads (Pure)
    Open Access
    File
  • 5 Downloads (Pure)

    ASPIRE-3-PREVENT: a cross-sectional survey of preventive care after a coronary event across the UK

    Jennings, C. S., Kotseva, K., Bassett, P., Adamska, A., Wood, D. & ASPIRE-3-PREVENT Investigators, 29 Apr 2020, In : Open Heart. 7, 1, p. 1-10 10 p., e001196.

    Research output: Contribution to journalArticle

    Open Access
    File
  • 10 Downloads (Pure)

    Biomarkers of Aortopathy in Marfan Syndrome

    Iskandar, Z., Mordi, I., Lang, C., Huang, J. & Choy, A., 1 Mar 2020, In : Cardiology in Review. 28, 2, p. 92-97 6 p.

    Research output: Contribution to journalReview article

  • Chronotherapy in hypertension: the devil is in the details

    Guthrie, G., TIME study Steering Committee, Poulter, N., Macdonald, T., Ford, I., Mackenzie, I., Findlay, E., Williams, B., Brown, M., Lang, C. & Webb, D., 21 Apr 2020, In : European Heart Journal. 41, 16, p. 1606-1607 2 p.

    Research output: Contribution to journalComment/debate

  • Prizes

    American Federation of Clinical Research Trainee Investigator Award

    Lang, Chim (Recipient), 1994

    Prize: Prize (including medals and awards)

    ASEAN Congress of Cardiology Young Investigator Award

    Lang, Chim (Recipient), 1996

    Prize: Prize (including medals and awards)

    British Pharmacological Society's, BrAPP PRIZE and MEDAL.

    Lang, Chim (Recipient), 1993

    Prize: Prize (including medals and awards)

    Fulbright Scholarship

    Lang, Chim (Recipient), 2001

    Prize: Prize (including medals and awards)

    Activities

    • 13 Invited talk
    • 2 Participation in conference
    • 1 Lecture

    ‘Blood pressure and heart failure: Some of the complexities of a love hate relationship.

    Chim Lang (Speaker)

    1 Sep 2014

    Activity: Talk or presentation typesInvited talk

    “Diabetes and Heart failure: Update on research and treatment’

    Chim Lang (Speaker)

    1 Aug 2014

    Activity: Talk or presentation typesInvited talk

    Diabetes UK Professional Conference 2013

    Chim C. Lang (Participant)

    13 Mar 201315 Mar 2013

    Activity: Participating in or organising an event typesParticipation in conference

    ‘Off Target Cardiovascular Effects of Diabetic Therapies’.

    Chim Lang (Speaker)

    1 Oct 2012

    Activity: Talk or presentation typesInvited talk

    Diabetic heart disease

    Chim Lang (Speaker)

    1 Mar 2009

    Activity: Talk or presentation typesInvited talk

    Press / Media

    Diabetes drug could help reduce cardiovascular disease

    Chim Lang

    22/08/16

    1 Media contribution

    Press/Media: Research

    BBC News. Type 2 diabetes drug 'could treat other conditions'

    Chim Lang

    19/08/16

    1 Media contribution

    Press/Media: Research

    Type 2 diabetes drug 'could treat other conditions'

    Chim C. Lang

    19/08/16

    1 item of Media coverage

    Press/Media: Research

    'Super-dose statins can add years to our lives,' says doctors

    Chim Lang

    21/02/14

    1 item of Media coverage

    Press/Media: Research